Cui X, Zhu Y, Zeng L, Zhang M, Uddin A, Gillespie TW, McCullough LE, Zhao S, Torres MA, Wan Y (2025) Pharmacological dissection identifies retatrutide overcomes the therapeutic barrier of obese TNBC treatments through suppressing the interplay between glycosylation and ubiquitylation of YAP
Combining medication with resistance training helps preserve lean muscle mass and may improve body composition outcomes
It also states that most providers currently advise against the combination
31: 98395 Kulwichit W, Torranin P
Approved Uses Tirzepatide : Currently approved by the FDA for the treatment of type 2 diabetes
Known as a Celebrity Aesthetic Physician, Dr